Heart rhythm medication
Pro Research Analysisby 
Searched over 200M research papers
Heart Rhythm Medication: An Overview
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation
Non-vitamin K antagonist oral anticoagulants (NOACs) have become the preferred choice over vitamin K antagonists (VKAs) for preventing stroke in patients with atrial fibrillation (AF). NOACs are particularly favored for patients newly starting on anticoagulation therapy. The European Heart Rhythm Association (EHRA) has provided a comprehensive guide addressing various clinical scenarios involving NOACs, including eligibility, start-up and follow-up schemes, adherence, switching between anticoagulants, and managing dosing errors and bleeding complications.
Impact of Antiarrhythmic Drugs on Heart Rhythm
Class I and III Antiarrhythmic Drugs Post-Ablation
Class I and III antiarrhythmic drugs are commonly used to maintain sinus rhythm after catheter ablation for AF. Evidence suggests that these drugs can reduce the recurrence of atrial tachyarrhythmias (ATa) within the first six months post-ablation, although their long-term benefits remain uncertain. These medications also likely reduce hospitalizations for ATa in the short term.
New Antiarrhythmic Agents
Several new antiarrhythmic agents, including amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, and verapamil, have shown efficacy in suppressing cardiac arrhythmias. Each of these drugs has unique clinical pharmacology and side effect profiles, making them suitable for different patient needs.
Beta Blockers in Heart Failure with Atrial Fibrillation
Beta blockers are a standard treatment for heart failure with reduced ejection fraction. However, their efficacy in patients with concomitant atrial fibrillation is less clear. A meta-analysis found that beta blockers significantly reduce all-cause mortality in patients with heart failure and sinus rhythm but not in those with atrial fibrillation. This suggests that beta blockers should not be the preferred rate-control medication in patients with both conditions.
Drug-Induced Arrhythmias
Many medications, including antiarrhythmic agents, antimicrobials, psychotropic drugs, and methadone, can induce arrhythmias such as torsades de pointes, bradyarrhythmias, and atrial fibrillation. Awareness of these potential side effects and the implementation of monitoring strategies are crucial for preventing serious outcomes, including sudden cardiac death.
Conclusion
Heart rhythm medications, including NOACs, Class I and III antiarrhythmic drugs, and beta blockers, play a critical role in managing conditions like atrial fibrillation and heart failure. While NOACs are preferred for stroke prevention in AF, the benefits of antiarrhythmic drugs post-ablation and beta blockers in heart failure with AF require careful consideration. Additionally, the risk of drug-induced arrhythmias underscores the importance of vigilant monitoring and personalized treatment strategies.
Sources and full results
Most relevant research papers on this topic